S1R:FRA
Shanghai Pharmaceuticals Holding Co Ltd
€1.20
arrow_downward
-0.83%(-0.0100) 1D
Oct 1, 8:10:02 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for S1R...
Open
€1.20
High
€1.20
Low
€1.20
Mkt. cap
63.32B
Avg. vol.
209.00
Volume
0.00
52-wk high
€1.37
52-wk low
€1.16
No. of employees
49K
Open
€1.20
High
€1.20
Low
€1.20
Mkt. cap
63.32B
Avg. vol.
209.00
Volume
0.00
52-wk high
€1.37
52-wk low
€1.16
No. of employees
49K
News stories
From web sources and news partners
The Chronicle-Journal
·
15 minutes ago
McCormick (NYSE:MKC) Posts Better-Than-Expected Sales In Q3 2026
Yahoo Finance
·
2 hours ago
S&P 500 alarm bells are starting to go off
TradingView
·
1 hour ago
Accelevation, Data Center Infrastructure Platform, Files for Nasdaq $540M IPO
Bloomberg.com
·
3 hours ago
Asian Stocks Eye Rough Start After US Reversal: Markets Wrap
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holding Co Ltd